Universitat Pompeu-Fabra;Institució Catalana de Recerca i Estudis Avançats
发明人:
申请号：
EP11382207.6
公开号：
EP2535412A1
申请日:
2011.06.17
申请国别(地区):
EP
年份:
2012
代理人:
摘要：
The invention provides a miRNA-21 inhibitor and pharmaceutical compositions comprising said miRNA-21 inhibitor together with pharmaceutical excipients and carriers for use in the treatment of a muscular dystrophy and/or a muscular dystrophy-like myopathy. Particularly, the miRNA-21 inhibitors and pharmaceutical compositions comprising the same are for use in the regeneration of skeletal muscle in muscular dystrophy and/or a muscular dystrophy-like myopathy patients.
